Healthcare technology company Veradigm disclosed it expects it misstated revenue by approximately $40 million during its 2021 and 2022 reporting periods.
Veradigm previously disclosed it misstated revenues going back to the third quarter of 2021 by $20 million, but an expanded audit discovered additional problems leading to the updated total, the company stated in a regulatory filing with the Securities and Exchange Commission (SEC) on Wednesday.
